Abstract
Canine leishmaniosis (CanL) is a vector-borne disease caused by the protozoan Leishmania (Leishmania) infantum species [syn. L. (L.) infantum chagasi species in the Americas] which is transmitted by the bite of a female phlebotomine sand fly. This parasitosis is endemic and affect millions of dogs in Asia, the Americas and the Mediterranean basin. Domestic dogs are the main hosts and the main reservoir hosts for human zoonotic leishmaniosis. The outcome of infection is a consequence of intricate interactions between the protozoan and the immunological and genetic background of the host. Clinical manifestations can range from subclinical infection to very severe disease. Early detection of infected dogs, their close surveillance and treatment are essential to control the dissemination of the parasite among other dogs, being also a pivotal element for the control of human zoonotic leishmaniosis. Hence, the identification of biomarkers for the confirmation of Leishmania infection, disease and determination of an appropriate treatment would represent an important tool to assist clinicians in diagnosis, monitoring and in giving a realistic prognosis to subclinical infected and sick dogs. Here, we review the recent advances in the identification of Leishmania infantum biomarkers, focusing on those related to parasite exposure, susceptibility to infection and disease development. Markers related to the pathogenesis of the disease and to monitoring the evolution of leishmaniosis and treatment outcome are also summarized. Data emphasizes the complexity of parasite-host interactions and that a single biomarker cannot be used alone for CanL diagnosis or prognosis. Nevertheless, results are encouraging and future research to explore the potential clinical application of biomarkers is warranted.
Highlights
CANINE LEISHMANIOSISCanine leishmaniosis (CanL) is a vector-borne zoonotic protozoan disease caused by Leishmania (Leishmania) infantum species [syn
Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Lisbon, Portugal
Candidate marker on chromosome 1 is related with notch signaling, which is key for macrophage activity and for T cell cluster of differentiation 4 (CD4+), while the candidate marker of chromosome 2 is related with the expression of interleukin 2 (IL-2) and IL-15, two cytokines with a pivotal role in the control and resolution of Leishmania infection (Utsunomiya et al, 2015)
Summary
Canine leishmaniosis (CanL) is a vector-borne zoonotic protozoan disease caused by Leishmania (Leishmania) infantum species [syn. Similar results were obtained with L. longipalpis; while Solcà et al (2016) observed an increase in the number of dogs displaying antibodies to L. longipalpis saliva along with high parasite load, and with disease severity, in the work performed by Quinnell et al (2018) no association was observed between exposure to sand fly bites and disease progression One reason for these contradictory results could be the fact that, with the exception of the work performed by Kostalova et al (2017), anti-saliva antibodies have been detected using the whole content of the salivary glands reducing the specificity of detection due to a higher likelihood of cross-reactivity with saliva components from other sympatric non-vector phlebotomine sand fly species (Andrade and Teixeira, 2012; Lestinova et al, 2017). Candidate marker on chromosome 1 is related with notch signaling, which is key for macrophage activity and for T cell cluster of differentiation 4 (CD4+), while the candidate marker of chromosome 2 is related with the expression of interleukin 2 (IL-2) and IL-15, two cytokines with a pivotal role in the control and resolution of Leishmania infection (Utsunomiya et al, 2015)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
